Mahamaya Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve We wish to inform you ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mahamaya Lifesciences Limited has informed BSE that a Board Meeting is scheduled for May 25, 2026. The meeting will consider and approve the Audited Standalone and Consolidated Financial Results for the half year and financial year ended March 31, 2026, along with the Audit Report. The company has also confirmed that the Trading Window remains closed and will reopen only 48 hours after the financial results are declared, in compliance with SEBI's Insider Trading Regulations. This is a routine intimation under SEBI Listing Regulations and does not contain any financial performance details or auditor opinions at this stage.
This is a standard pre-results disclosure notice. The actual financial performance details, auditor opinions, and any significant findings will be known only after the meeting on May 25, 2026. Until then, the stock may experience increased volatility due to the closed trading window.